Market Place
Sourcing Support
All News #Library
Biotech
Medicinova To Participate At The 38th Annual ROTH Conference
16 Mar 2026 //
GLOBENEWSWIRE
MediciNova Completes MN-166 Enrollment in CIPN Prevention Trial
18 Dec 2025 //
GLOBENEWSWIRE
Medicinova Updates MN-166 Phase 2/3 ALS Trial At ALS/MND
08 Dec 2025 //
GLOBENEWSWIRE
MediciNova Wins R&D Innovation Award at 2025 Biotech Awards
06 Nov 2025 //
GLOBENEWSWIRE
MediciNova Compounds Show Novel Approach for Atherosclerosis
30 Oct 2025 //
GLOBENEWSWIRE
Medicinova To Present At LD Micro XIX Investor Conference
06 Oct 2025 //
GLOBENEWSWIRE
MediciNova Presents COMBAT-ALS Trial Poster at 36th ALS/MND
16 Sep 2025 //
GLOBENEWSWIRE
MediciNova Receives Patent Notice for MN-166 in Post-COVID Condition
29 Aug 2024 //
GLOBENEWSWIRE
MediciNova`s MN-166 Glioblastoma Data At ASCO 2024
03 Jun 2024 //
GLOBENEWSWIRE
MediciNova`s Collaborator Initiates Development of a Gene Therapy Product
27 Oct 2023 //
GLOBENEWSWIRE
MediciNova Receives Gene Therapy Milestone Payment
04 Oct 2023 //
GLOBENEWSWIRE
MediciNova Announces Data Regarding MN-166 in Glioblastoma Tumor Tissue Analysis
20 Feb 2023 //
GLOBENEWSWIRE
MediciNova Announces Completion of Enrollment in PII Trial Evaluating MN-166
12 Jan 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.